OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gallbladder cancer
Juan Carlos Roa, Patricia García, Vinay K. Kapoor, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 180
Juan Carlos Roa, Patricia García, Vinay K. Kapoor, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 180
Showing 1-25 of 180 citing articles:
Bacteria in cancer initiation, promotion and progression
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 149
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 149
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
Shaoming Wang, Rongshou Zheng, Jiayue Li, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 229-237
Open Access | Times Cited: 78
Shaoming Wang, Rongshou Zheng, Jiayue Li, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 229-237
Open Access | Times Cited: 78
Gallbladder cancer: current and future treatment options
Yanzhao Zhou, Kun Yuan, Yi Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 40
Yanzhao Zhou, Kun Yuan, Yi Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 40
Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study
Anita Balakrishnan, Petros Barmpounakis, Nikolaos Demiris, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101951-101951
Open Access | Times Cited: 27
Anita Balakrishnan, Petros Barmpounakis, Nikolaos Demiris, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101951-101951
Open Access | Times Cited: 27
YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer
Ziyi Wang, Shijia Wang, Ziheng Jia, et al.
Cancer Letters (2023) Vol. 563, pp. 216184-216184
Closed Access | Times Cited: 27
Ziyi Wang, Shijia Wang, Ziheng Jia, et al.
Cancer Letters (2023) Vol. 563, pp. 216184-216184
Closed Access | Times Cited: 27
Global, regional, and national burden and trends analysis of gallbladder and biliary tract cancer from 1990 to 2019 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2019
Jiao Su, Yuanhao Liang, Xiao‐Feng He
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 13
Jiao Su, Yuanhao Liang, Xiao‐Feng He
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 13
Compressive stresses in cancer: characterization and implications for tumour progression and treatment
Julia A Linke, Lance L. Munn, Rakesh K. Jain
Nature reviews. Cancer (2024) Vol. 24, Iss. 11, pp. 768-791
Closed Access | Times Cited: 10
Julia A Linke, Lance L. Munn, Rakesh K. Jain
Nature reviews. Cancer (2024) Vol. 24, Iss. 11, pp. 768-791
Closed Access | Times Cited: 10
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States
Michael H. Storandt, Sri Harsha Tella, Mikolaj A. Wieczorek, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 684-684
Open Access | Times Cited: 9
Michael H. Storandt, Sri Harsha Tella, Mikolaj A. Wieczorek, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 684-684
Open Access | Times Cited: 9
The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis
Kui Wang, Suijian Wang, Xianzheng Qin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Kui Wang, Suijian Wang, Xianzheng Qin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101171-101171
Open Access | Times Cited: 1
Lorenza Rimassa, Shahid A. Khan, Bas Groot Koerkamp, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101171-101171
Open Access | Times Cited: 1
Deep-learning enabled ultrasound based detection of gallbladder cancer in northern India: a prospective diagnostic study
Pankaj Gupta, Soumen Basu, Pratyaksha Rana, et al.
The Lancet Regional Health - Southeast Asia (2023) Vol. 24, pp. 100279-100279
Open Access | Times Cited: 20
Pankaj Gupta, Soumen Basu, Pratyaksha Rana, et al.
The Lancet Regional Health - Southeast Asia (2023) Vol. 24, pp. 100279-100279
Open Access | Times Cited: 20
DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis
Sunwang Xu, Zhiqing Yuan, Cen Jiang, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 6
Sunwang Xu, Zhiqing Yuan, Cen Jiang, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 6
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 6
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 6
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 6
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 6
The State of Systematic Therapies in Clinic for Hepatobiliary Cancers
Weixun Chen, Zhengnan Hu, Ganxun Li, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 629-649
Open Access | Times Cited: 6
Weixun Chen, Zhengnan Hu, Ganxun Li, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 629-649
Open Access | Times Cited: 6
Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy
Yanjun Sun, Jun-feng Gong, Zhuang Li, et al.
Postgraduate Medicine (2024) Vol. 136, Iss. 3, pp. 278-291
Closed Access | Times Cited: 6
Yanjun Sun, Jun-feng Gong, Zhuang Li, et al.
Postgraduate Medicine (2024) Vol. 136, Iss. 3, pp. 278-291
Closed Access | Times Cited: 6
Artificial intelligence applications in the diagnosis of gallbladder neoplasms through ultrasound: A review
Sara Dadjouy, Hedieh Sajedi
Biomedical Signal Processing and Control (2024) Vol. 93, pp. 106149-106149
Closed Access | Times Cited: 5
Sara Dadjouy, Hedieh Sajedi
Biomedical Signal Processing and Control (2024) Vol. 93, pp. 106149-106149
Closed Access | Times Cited: 5
Multi-model analysis of gallbladder cancer reveals the role of OxLDL-absorbing neutrophils in promoting liver invasion
Dongning Rao, Jiaxin Li, Mao Zhang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Dongning Rao, Jiaxin Li, Mao Zhang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis
Yizhi Wang, Yang Kong, Qifan Yang, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 4, pp. 108047-108047
Closed Access | Times Cited: 5
Yizhi Wang, Yang Kong, Qifan Yang, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 4, pp. 108047-108047
Closed Access | Times Cited: 5
Intestinal microbiota and biliary system diseases
Hua Wang, Junfeng Gong, Jingyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Hua Wang, Junfeng Gong, Jingyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Comprehensive single-cell analysis deciphered microenvironmental dynamics and immune regulator olfactomedin 4 in pathogenesis of gallbladder cancer
Huisi He, Shuzhen Chen, Yong Yu, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1529-1542
Open Access | Times Cited: 5
Huisi He, Shuzhen Chen, Yong Yu, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1529-1542
Open Access | Times Cited: 5
NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14
Ziyi Yang, Cheng Zhao, Shilei Liu, et al.
Cancer Letters (2024) Vol. 587, pp. 216703-216703
Open Access | Times Cited: 4
Ziyi Yang, Cheng Zhao, Shilei Liu, et al.
Cancer Letters (2024) Vol. 587, pp. 216703-216703
Open Access | Times Cited: 4
Jiemin Chen, Xuesong Bai, Wen-Qin Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 4
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3 /HIF ‐1α Signaling
Lichao Ji, Yingjie Chai, Chenhao Tong, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 1
Closed Access
Lichao Ji, Yingjie Chai, Chenhao Tong, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 1
Closed Access
